The Trump Administration has finalized new rules changing the maximum length of short-term, limited duration health plans, a step it claims will increase health insurance options for Americans. Issued by the US Departments of Health and Human Services (HHS), Labor and Treasury, the new...
Read More“Change is coming to prescription drug pricing,” is the message from Health and Human Services (HHS) secretary Alex Azar, who made the comments at the annual meeting of 340B Health, a trade group for 340B hospitals. At the meeting, he suggested the existing 340B system is in need...
Read MoreConcern over the cost of cost of health care resulted in more than one-quarter (27 percent) of American adults forgoing medical treatment over concerns about their ability to pay, according to a recent report. The Federal Reserve’s Report on the Economic Well-Being of US Households in 2017...
Read MoreSenior patients with diabetes could be more than $350 better off each year if a share of negotiated manufacturer rebates is passed on the patients at the point of sale, according to recent IHS Markit analysis commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA). Passing...
Read MorePresident Donald Trump has unveiled a “blueprint” to lower the price of prescription drugs in the United States. The plans include building on the existing administrative efforts of the US Food and Drug Administration (FDA) to increase generic drug approvals, reforms to the Medicare...
Read MoreThe high cost of prescription medication remains a major concern for a significant proportion of Americans, with eight out ten respondents to the latest Kaiser Health Tracking Poll describing prices as “unreasonable”. The results showed a rise in the proportion of the American public...
Read MoreAnnual per patient outpatient pharmacy costs at hospitals participating in the 340B Drug Discount Program are significantly higher than in non-340B hospitals, according to new analysis from the Pharmaceutical Research and Manufacturers of America (PhRMA). The analysis, prepared by Milliman and...
Read MorePatients with health plans with value-based contracts for diabetes, high cholesterol, and HIV medication benefited from significantly cheaper co-pays than patients on other plans, according to new data from the Pharmaceutical Research and Manufacturers of America (PhRMA). On average, these...
Read MoreGovernor Edmund G Brown Jr of California has signed legislation SB 17 aimed at improving the transparency of prescription drug prices in the Golden State. It is hoped the Drug Price Transparency Bill, authored by Senator Ed Hernandez, will curb price hikes and help patients struggling with...
Read MoreMore than one-quarter (27 percent) of patients between 50 and 80 years of age find the cost of their prescription medication a burden, according to the latest National Poll on Healthy Aging conducted by the University of Michigan. The study looked at responses from approximately 2,000 people within...
Read MoreNevada could become the first state in the United States. to allow all residents to buy into the Medicaid program, no matter what their income level. The state's legislature passed the bill earlier this month, but the final decision rests with Republican governor Brian Sandoval, who has the power...
Read MoreMany patients with chronic obstructive pulmonary disease (COPD) who have Medicare Part D struggle to pay for medication and inhalers, it has been suggested. A report published in the Journal of the American Medical Association (JAMA) revealed one in nine Medicare beneficiaries have COPD. The...
Read MoreInsured patients may lose prescription drug cover following yesterday's passing of the American Health Care Act (AHCA) by the US House of Representatives. The legislation includes provisions allowing states to opt out of certain protections offered under the Affordable Care Act (ACA). If passed by...
Read MoreMany patients with health insurance are still over-paying for their prescriptions, according to Pharmaceutical Research and Manufacturers of America (PhRMA). Priscilla VanderVeer, spokeswoman for the organization, observed many patients still have a "hard time affording their medicines". She...
Read MoreThe president and chief executive of Pharmaceutical Research and Manufacturers of America (PhRMA) has highlighted the importance of discounts on prescriptions. His comments come following the launch of the organization's "Share the Savings" campaign. He suggested patients with access to discounts...
Read More
